Long-term bosentan effective in paediatric PAH

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1505, 2005-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bosentan potentially cost effective in PAH

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Bosentan potentially cost effective in PAH

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Long-term benefits of bosentan in pulmonary arterial hypertension

By  

Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Long-term omeprazole effective in GORD

By  

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Long-Term Consequences of Drugs on the Paediatric Cardiovascular System

By Hausner Elizabeth   Fiszman Monica L.   Hanig Joseph   Harlow Patricia   Zornberg Gwen   Sobel Solomon  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1083-1096

Adis International

Access to resources Recommend Favorite